Cytospire Therapeutics

Cytospire Therapeutics is a biotech company in London, United States, founded in 2023. It has raised $182.0M across 2 rounds, most recently an $83.0M Venture Round in May 2026.

Next generation immune cell engagers for cancer

Headquarters
London
Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$182.0M
Last Round
$83.0M Venture RoundMay 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Cytospire Therapeutics is a UK-based clinical-stage biotechnology company developing next-generation multispecific immune cell engagers for cancer treatment. Its lead programs are pan-gamma delta (γδ) T cell engagers designed to direct the innate and adaptive immune system against tumors, offering a safer and more tailored alternative to CD3-based engagers. The company was founded by leadership previously at Adaptate Biotherapeutics and GammaDelta Therapeutics, both acquired by Takeda Pharmaceuticals, and raised an oversubscribed £61 million ($83M) Series A in May 2026 led by 4BIO Capital.

Summary

It lists 11–50 employees. It has raised $182.0M in total across 2 rounds, most recently a $83.0M Venture Round in May 2026. Investors include 4BIO Capital, Servier Ventures and British Business Bank.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundMay 2026
$83.0M

Sign up to see all 2 events

Funding: Venture Round through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cytospire Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cytospire-therapeutics"><img src="https://indexed.vc/api/badge/company/cytospire-therapeutics" alt="Cytospire Therapeutics on Indexed.vc" width="260" height="76" /></a>